Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongshu Chen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Immunology|May 22, 2003
Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cellsDongshu Chen, Jianchuan Xia, Yasuhiro Tanaka, et al.
Cancer Cell|March 5, 2004
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agentsJian Ren, Naoki Agata, Dongshu Chen, et al.
Leukemia Research|October 12, 2004
Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblastsJianlin Gong, Shigeo Koido, Yoko Kato, et al.
Cancer Research|October 23, 2015
Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung CancerAlexandra B Lantermann, Dongshu Chen, Kaitlin McCutcheon, et al.
Journal of Medicinal Chemistry|May 18, 2016
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology InsightB Barry Touré, John Giraldes, Troy Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Nature Medicine|November 16, 2010
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathwayZainab Jagani, E Lorena Mora-Blanco, Courtney G Sansam, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Scientific Reports|January 15, 2021
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanismsYe Wang, Morvarid Mohseni, Angelo Grauel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Immunology|May 22, 2003
Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cellsDongshu Chen, Jianchuan Xia, Yasuhiro Tanaka, et al.
Cancer Cell|March 5, 2004
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agentsJian Ren, Naoki Agata, Dongshu Chen, et al.
Leukemia Research|October 12, 2004
Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblastsJianlin Gong, Shigeo Koido, Yoko Kato, et al.
Cancer Research|October 23, 2015
Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung CancerAlexandra B Lantermann, Dongshu Chen, Kaitlin McCutcheon, et al.
Journal of Medicinal Chemistry|May 18, 2016
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology InsightB Barry Touré, John Giraldes, Troy Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Nature Medicine|November 16, 2010
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathwayZainab Jagani, E Lorena Mora-Blanco, Courtney G Sansam, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Scientific Reports|January 15, 2021
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanismsYe Wang, Morvarid Mohseni, Angelo Grauel, et al.
Pageof 2